lsh semaglutide – lsh semaglutide the narrative matters

6 Early geroscience research is now exploring GLP-1/GIP medications for their role in impacting healthspan and longevity

Prebiotic fibers broadly have established research supporting their role in gut microbiota modulation

While BMI is an important starting point, healthcare providers evaluate the entire clinical picture, including current health conditions, weight history, previous treatment attempts, medication safety considerations, and insurance requirements

Ghusn and Hurtado, 2024)

"If taking medications that decrease appetite or insulin requirements, people with type 1 diabetes still must continue taking their long-acting insulin or using their insulin pump." Semaglutide, vomiting, and DKA: A case study In a 2023 case report, a person with type 1 arrived at an emergency room with ketoacidosis, after suffering nausea and vomiting attributed to taking Wegovy (semaglutide) prescribed by his endocrinologist for weight loss